Cholesterol in the retina: The best is yet to come

Progress in Retinal and Eye Research

Volumn 41, Issue , 2014, Pages 64-89

  Pikuleva, Irina A ^a   Curcio, Christine A ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Age related macular degeneration; Cholesterol; Choroid; Drusen; Lipoproteins; Retina

Indexed keywords

CHOLESTEROL; CYANOCOBALAMIN; FOLIC ACID; LIPOPROTEIN; PYRIDOXAMINE; PYRIDOXINE;

AGE RELATED MACULAR DEGENERATION; AGING; ATHEROSCLEROSIS; BRUCH MEMBRANE; DISEASE COURSE; DRUSEN; HOMEOSTASIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; RETINA; RETINA MACULA LUTEA; REVIEW; RISK FACTOR; VASCULAR BIOLOGY; ANIMAL; GENETICS; MACULAR DEGENERATION; METABOLISM;

ANIMALS; CHOLESTEROL; HOMEOSTASIS; HUMANS; LIPOPROTEINS; MACULAR DEGENERATION; RETINAL DRUSEN;

EID: 84925545770     PISSN: 13509462     EISSN: 18731635     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2014.03.002     Document Type: Review

References (335)

1. Anonymous Arandomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. AREDS Report No. 8. Arch. Ophthalmol. 2001, 119:1417-1436.
2. Anonymous Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III) final report. Circulation 2002, 106:3143-3421.
3. Anonymous Lutein+ zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. J. Am. Med. Assoc. 2013, 309:2005-2015.
4. Ablonczy Z., et al. Human retinal pigment epithelium cells as functional models for the RPE invivo. Investig. Ophthalmol. Vis. Sci. 2011, 52:8614-8620.
5. Acton J.H., et al. Drusen detection in retro-mode imaging by a scanning laser ophthalmoscope. Acta Ophthalmol. 2011, 89:e404-e411.
6. Ahmed J., et al. Measurement of blood flow through the retinal circulation of the cat during normoxia and hypoxemia using fluorescent microspheres. Microvasc. Res. 2001, 62:143-153.
7. Albert A.D., Boesze-Battaglia K. The role of cholesterol in rod outer segment membranes. Prog. Lipid Res. 2005, 44:99-124.
8. Aleman T.S., et al. Retinal structure in vitamin A deficiency as explored with multimodal imaging. Doc. Ophthalmol. 2013, 127:239-243.
9. Alm A., Bill A. Ocular and optic nerve blood flow at normal and increased intraocular pressures in monkeys (Macaca irus): a study with radioactively labelled microspheres including flow determinations in brain and some other tissues. Exp. Eye Res. 1973, 15:15-29.
10. Amaral J., et al. 7-Ketocholesterol induces inflammation and angiogenesis invivo: a novel rat model. PloS One 2013, 8:e56099.
11. Amaratunga A., et al. Apolipoprotein E is synthesized in the retina by Muller glial cells, secreted into the vitreous, and rapidly transported into the optic nerve by retinal ganglion cells. J. Biol. Chem. 1996, 271:5628-5632.
12. Anand-Apte B., Hollyfield J.G. Developmental anatomy of the retinal and choroidal vasculature. Immunology, Inflammation and Diseases of the Eye 2011, 186-192. Academic Press, San Diego, CA. D.A. Dart, R. Dana, P. D'amore, J.Y. Niederkorn (Eds.).
13. Anderson D.H., et al. Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. Am. J. Ophthalmol. 2001, 131:767-781.
14. Anderson D.H., et al. Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. Exp. Eye Res. 2004, 78:243-256.
15. Andersson S., et al. Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J. Biol. Chem. 1989, 264:8222-8229.
16. Anitschkow N. Ueber die veranderungen der kaninchenaorta bei experimenteller cholesterinsteatose. Beitr. Pathol. Anat. 1913, 56:379-404.
17. Arnold J.J., et al. Reticular pseudodrusen. A risk factor in age-related maculopathy. Retina 1995, 15:183-191.
18. Baba T., et al. Arat model for choroidal neovascularization using subretinal lipid hydroperoxide Injection. Am. J. Pathol. 2010, 176:3085-3097.
19. Babiker A., et al. Elimination of cholesterol as cholestenoic acid in human lung by sterol 27-hydroxylase: evidence that most of this steroid in the circulation is of pulmonary origin. J. Lipid Res. 1999, 40:1417-1425.
20. Babiker A., et al. Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism. Comparison with high density lipoprotein-mediated reverse cholesterol transport. J. Biol. Chem. 1997, 272:26253-26261.
21. Bairaiti A., Orzalesi N. The ultrastructure of the pigment epithelium and of the photoreceptor-pigment epithelium interface. J. Ultrastruct. Res. 1963, 9:484-496.
22. Barathi V.A., et al. Effects of simvastatin on retinal structure and function of a high-fat atherogenic mouse model of thickened Bruch's membrane. Investig. Ophthalmol. Vis. Sci. 2014, 55:460-468.
23. Bazan N.G., et al. Docosahexaenoic acid uptake and metabolism in photoreceptors: retinal conservation by an efficient retinal pigment epithelial cell-mediated recycling process. Adv. Exp. Med. Biol. 1992, 318:295-306.
24. Beebe D.C. The use of cell lines to "model" ocular tissues: cautionary tales. Investig. Ophthalmol. Vis. Sci. 2013, 54.
25. Beltran W.A., et al. Canine retina has a primate fovea-like bouquet of cone photoreceptors which is affected by inherited macular degenerations. PloS One 2014, 9:e90390.
26. Berson E.L. Experimental and therapeutic aspects of photic damage to the retina. Investig. Ophthalmol. Vis. Sci. 1973, 12:35-44.
27. Bird A.C., et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv. Ophthalmol. 1995, 39:367-374.
28. Bird A.C., Marshall J. Retinal pigment epithelial detachments in the elderly. Trans. Ophthalmol. Soc. U. K. 1986, 105:674-682.
29. Bjorkhem I. Are side-chain oxidized oxysterols regulators also invivo?. J. Lipid Res. 2009, 50(Suppl):S213-S218.
30. Bjorkhem I., et al. Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol. The Metabolic and Molecular Bases of Inherited Disease 1995, 2073-2099. McGraw-Hill, New York. seventh ed. A.L. Scriver, A.L. Beaudet, W.S. Sly, D. Valle, B. Childs (Eds.).
31. Bjorkhem I., et al. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J. Lipid Res. 1998, 39:1594-1600.
32. Bjorkhem I., Meaney S. Brain cholesterol: long secret life behind a barrier. Arterioscler. Thromb. Vasc. Biol. 2004, 24:806-815.
33. Bobryshev Y.V. Dendritic cells and their role in atherogenesis. Lab. Investig. 2010, 90:970-984.
34. Boesze-Battaglia K., et al. Relationship of cholesterol content to spatial distribution and age of disk membranes in retinal rod outer segments. J. Biol. Chem. 1990, 265:18867-18870.
35. Boesze-Battaglia K., et al. Cholesterol heterogeneity in bovine rod outer segment disk membranes. J. Biol. Chem. 1989, 264:8151-8155.
36. Bok D., Young R.W. Phagocytic Properties of the Retinal Pigment Epithelium 1979, Harvard University Press Cambridge, MA.
37. Breslow J.L. Transgenic mouse models of lipoprotein metabolism and atherosclerosis. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:8314-8318.
38. Bressler S.B., et al. Age-related macular degeneration: nonneovascular early AMD, intermediate AMD, and geographic atrophy. Retina 2006, 1041-1074. Mosby, St Louis. fourth ed. S.J. Ryan (Ed.).
39. Bretillon L., et al. ApoB100, LDLR-/- mice exhibit reduced electroretinographic response and cholesteryl esters deposits in the retina. Investig. Ophthalmol. Vis. Sci. 2008, 49:1307-1314.
40. Bretillon L., et al. Cholesterol-24S-hydroxylase (CYP46A1) is specifically expressed in neurons of the neural retina. Curr. Eye Res. 2007, 32:361-366.
41. Bretillon L., et al. Lipid and fatty acid profile of the retina, retinal pigment epithelium/choroid, and the lacrimal gland, and associations with adipose tissue fatty acids in human subjects. Exp. Eye Res. 2008, 87:521-528.
42. Bringmann A., et al. Muller cells in the healthy and diseased retina. Prog. Retin. Eye. Res. 2006, 25:397-424.
43. Broekhuyse R.M. Lipids in tissues of the eye. VII. Changes in concentration and composition of sphingomyelins, cholesterol esters and other lipids in aging sclera. Biochim. Biophys. Acta 1972, 280:637-645.
44. Brown M.S., Goldstein J.L. Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL. J. Lipid Res. 2009, 50(Suppl):S15-S27.
45. Brunzell J.D., et al. The effect of hepatic lipase on coronary artery disease in humans is influenced by the underlying lipoprotein phenotype. Biochim. Biophys. Acta 2012, 1821:365-372.
46. Burglin T.R. The Hedgehog protein family. Genome Biol. 2008, 9:241.
47. Caldes C., et al. Phenol group in pyridoxamine acts as a stabilizing element for its carbinolamines and Schiff bases. Chem. Biodivers. 2011, 8:1318-1332.
48. Cali J.J., Russell D.W. Characterization of human sterol 27-hydroxylase. A mitochondrial cytochrome P-450 that catalyzes multiple oxidation reactions in bile acid biosynthesis. J. Biol. Chem. 1991, 266:7774-7778.
49. Castanho M.A., et al. Absorption and fluorescence spectra of polyene antibiotics in the presence of cholesterol. J. Biol. Chem. 1992, 267:204-209.
50. Charvet C., et al. Isolevuglandins and mitochondrial enzymes in the retina: mass spectrometry detection of post-translational modification of sterol-metabolizing CYP27A1. J. Biol. Chem. 2011, 286:20413-20422.
51. Charvet C.D., et al. Posttranslational modification by an isolevuglandin diminishes activity of the mitochondrial cytochrome P450 27A1. J. Lipid Res. 2013, 54:1421-1429.
52. Charvet C.D., et al. Pretreatment with pyridoxamine mitigates isolevuglandin-associated retinal effects in mice exposed to bright light. J. Biol. Chem. 2013, 288:29267-29280.
53. Chen J., et al. eNOS mediates TO90317 treatment-induced angiogenesis and functional outcome after stroke in mice. Stroke J. Cereb. Circ. 2009, 40:2532-2538.
54. Chen W., et al. Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:7401-7406.
55. Cheng J.B., et al. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:7711-7715.
56. Chiu C.J., et al. Does eating particular diets alter the risk of age-related macular degeneration in users of the Age-Related Eye Disease Study supplements?. Br. J. Ophthalmol. 2009, 93:1241-1246.
57. Cho E., et al. Prospective study of dietary fat and the risk of age-related macular degeneration. Am. J. Clin. Nutr. 2001, 73:209-218.
58. Choi J.H., et al. Flt3 signaling-dependent dendritic cells protect against atherosclerosis. Immunity 2011, 35:819-831.
59. Chong E.W., et al. Fat consumption and its association with age-related macular degeneration. Arch. Ophthalmol. 2009, 127:674-680.
60. Chowers I., et al. Long-term assessment of combined vitamin A and E treatment for the prevention of retinal degeneration in abetalipoproteinaemia and hypobetalipoproteinaemia patients. Eye 2001, 15:525-530.
61. Christen W.G., et al. Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the women's antioxidant and folic acid cardiovascular study. Arch. Intern. Med. 2009, 169:335-341.
62. Claudepierre T., et al. Lack of Niemann-Pick type C1 induces age-related degeneration in the mouse retina. Mol. Cell. Neurosci. 2010, 43:164-176.
63. Crabb J.W., et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:14682-14687.
64. Cruysberg J.R., et al. Ocular and systemic manifestations of cerebrotendinous xanthomatosis. Am. J. Ophthalmol. 1995, 120:597-604.
65. Curcio C.A., et al. Apolipoprotein B-containing lipoproteins in retinal aging and age-related maculopathy. J. Lipid Res. 2010, 51:451-467.
66. Curcio C.A., et al. Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins. Prog. Retin. Eye Res. 2009, 28:393-422.
67. Curcio C.A., et al. The oil spill in ageing Bruch membrane. Br. J. Ophthalmol. 2011, 95:1638-1645.
68. Curcio C.A., et al. Human chorioretinal layer thicknesses measured using macula-wide high resolution histological sections. Investig. Ophthalmol. Vis. Sci. 2011, 52:3943-3954.
69. Curcio C.A., et al. Subretinal drusenoid deposits in non-neovascular age-related macular degeneration: morphology, prevalence, topography, and biogenesis model. Retina 2013, 33:265-276.
70. Curcio C.A., et al. Aging of the human photoreceptor mosaic: evidence for selective vulnerability of rods in central retina. Investi. Ophthalmol. Vis. Sci. 1993, 34:3278-3296.
71. Curcio C.A., et al. Accumulation of cholesterol with age in human Bruch's membrane. Investi. Ophthalmol. Vis. Sci. 2001, 42:265-274.
72. Curcio C.A., et al. Esterified and unesterified cholesterol in drusen and basal deposits of eyes with age-related maculopathy. Exp. Eye Res. 2005, 81(6):731-741.
73. Curcio C.A., et al. Basal deposits and drusen in eyes with age-related maculopathy: evidence for solid lipid particles. Exp. Eye Res. 2005, 80:761-775.
74. Curcio C.A., et al. Histochemistry and lipid profiling combine for insights into aging and age-related maculopathy. Methods in Molecular Biology/Lipomics 2009, 267-281. Humana Press, New York. D. Armstrong (Ed.).
75. Curcio C.A., et al. Human photoreceptor topography. J. Comp. Neurol. 1990, 292:497-523.
76. Dashti N., et al. Plasma apolipoproteins and risk for age-related maculopathy. Br. J. Ophthalmol. 2006, 90:1028-1033. (Erratum Br J Ophthalmol. 2007 Mar;1091(1023):1403.).
77. Davis M.D., et al. The age-related eye disease study severity scale for age-related macular degeneration: AREDS report no. 17. Arch. Ophthalmol. 2005, 123:1484-1498.
78. DeBose-Boyd R.A. Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase. Cell Res. 2008, 18:609-621.
79. Deeb S.S., et al. Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet. J. Lipid Res. 2003, 44:1279-1286.
80. Dietschy J.M., Turley S.D. Cholesterol metabolism in the brain. Curr. Opin. Lipidol. 2001, 12:105-112.
81. Dietschy J.M., Turley S.D. Control of cholesterol turnover in the mouse. J. Biol. Chem. 2002, 277:3801-3804.
82. Dietschy J.M., Turley S.D. Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J. Lipid Res. 2004, 45:1375-1397.
83. Dietschy J.M., et al. Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J. Lipid Res. 1993, 34:1637-1659.
84. Distler C., Dreher Z. Glia cells of the monkey retina - II. Müller cells. Vis. Res. 1996, 36:2381-2394.
85. Donders F. Beitrage zur pathologischen Anatomie des Auges. Arch. Für Ophthalmol. 1854, 1:106-118.
86. Dotti M.T., et al. Cerebrotendinous xanthomatosis: heterogeneity of clinical phenotype with evidence of previously undescribed ophthalmological findings. J. Inherit. Metab. Dis. 2001, 24:696-706.
87. Dowhan W., Bogdanov M. Functional roles of lipids in membranes. Biochemistry of Lipids, Lipoproteins and Membranes 2002, 1-35. Elsevier, Amsterdam. D.E. Vance, J.E. Vance (Eds.).
88. Drasdo N., et al. The length of Henle fibers in the human retina and a model of ganglion receptive field density in the visual field. Vis. Res. 2007, 47:2901-2911.
89. Dudley P.A., Anderson R.E. Phospholipid transfer protein from bovine retina with high activity towards retinal rod disc membranes. FEBS Lett. 1978, 95:57-60.
90. Duncan K.G., et al. Human retinal pigment epithelial cells express scavenger receptors BI and BII. Biochem. Biophys. Res. Commun. 2002, 292:1017-1022.
91. Duncan K.G., et al. Expression of reverse cholesterol transport proteins ATP-binding cassette A1 (ABCA1) and scavenger receptor BI (SR-BI) in the retina and retinal pigment epithelium. Br. J. Ophthalmol. 2009, 93:1116-1120.
92. Dwyer M.A., et al. Research resource: nuclear receptor atlas of human retinal pigment epithelial cells: potential relevance to age-related macular degeneration. Mol. Endocrinol. 2011, 25:360-372.
93. Dzeletovic S., et al. Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal. Biochem 1995, 225:73-80.
94. Ebrahimi K.B., et al. Decreased membrane complement regulators in the retinal pigmented epithelium contributes to age-related macular degeneration. J. Pathol. 2012, 229:729-742.
95. Elner V.M. Retinal pigment epithelial acid lipase activity and lipoprotein receptors: effects of dietary omega-3 fatty acids. Trans. Am. Ophthalmol. Soc. 2002, 100:301-338.
96. -/- mice. Investig. Ophthalmol. Vis. Sci. 2012, 53:4756.
97. Feeney-Burns L., et al. The fate of immunoreactive opsin following phagocytosis by pigment epithelium in human and monkey retinas. Investig. Ophthalmol. Vis. Sci. 1988, 29:708-719.
98. Ferris F.L., et al. Clinical classification of age-related macular degeneration. Ophthalmology 2013, 120:844-851.
99. Fleming C.P., et al. Depth resolved detection of lipid using spectroscopic optical coherence tomography. Biomed. Opt. Express 2013, 4:1269-1284.
100. Fliesler S.J. Lipids and lipid metabolism in the eye. J. Lipid Res. 2010, 51:1-3.
101. Fliesler S.J. Retinal degeneration in a rat model of Smith-Lemli-Opitz Syndrome: thinking beyond cholesterol deficiency. Adv. Exp. Med. Biol. 2010, 664:481-489.
102. Fliesler S.J., Anderson R.E. Chemistry and metabolism of lipids in the vertebrate retina. Prog. Lipid Res. 1983, 22:79-131.
103. Fliesler S.J., Bretillon L. The ins and outs of cholesterol in the vertebrate retina. J. Lipid Res. 2010, 51:3399-3413.
104. Fliesler S.J., et al. Invivo biosynthesis of cholesterol in the rat retina. FEBS Lett. 1993, 335:234-238.
105. Fliesler S.J., Keller R.K. Metabolism of [3H]farnesol to cholesterol and cholesterogenic intermediates in the living rat eye. Biochem. Biophys. Res. Commun. 1995, 210:695-702.
106. Fliesler S.J., Schroepfer G.J. Sterol composition of bovine retinal rod outer segment membranes and whole retinas. Biochim. Biophys. Acta 1982, 711:138-148.
107. Fliesler S.J. Partial rescue of retinal function and sterol steady-state in a rat model of Smith-Lemli-Opitz syndrome. Ped. Res. 2007, 61:273-278.
108. Fourgeux C., et al. 24S-hydroxycholesterol and cholesterol-24S-hydroxylase (CYP46A1) in the retina: from cholesterol homeostasis to pathophysiology of glaucoma. Chem. Phys. Lipids 2011, 164:496-499.
109. Fourgeux C., et al. Single nucleotide polymorphism in the cholesterol-24S-hydroxylase (CYP46A1) gene and its association with CFH and LOC387715 gene polymorphisms in age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 2012, 53:7026-7033.
110. Fourgeux C., et al. Primary open-angle glaucoma: association with cholesterol 24S-hydroxylase (CYP46A1) gene polymorphism and plasma 24-hydroxycholesterol levels. Investig. Ophthalmol. Vis. Sci. 2009, 50:5712-5717.
111. Freund K.B., et al. Do we need a new classification for choroidal neovascularization in age-related macular degeneration?. Retina 2010, 30:1333-1349.
112. Friedman E., et al. Pathogenesis of senile disciform degeneration of the macula, XXI Concilium Ophthalmologicum Mexico 1971, 454-458. Elsevier.
113. Fritsche L.G., et al. Seven new loci associated with age-related macular degeneration. Nat. Genet. 2013, 45:433-439. 439e431-432.
114. Fritsche L.G., et al. Age-related macular degeneration: genetics and biology coming together. Annu. Rev. Genomics Hum. Genet. 2014, 15. (in press).
115. Funatsu T., et al. Prolonged inhibition of cholesterol synthesis by atorvastatin inhibits apo B-100 and triglyceride secretion from HepG2 cells. Atherosclerosis 2001, 157:107-115.
116. Garland D.L., et al. Mouse genetics and proteomic analyses demonstrate a critical role for complement in a model of DHRD/ML, an inherited macular degeneration. Hum. Mol. Genet. 2014, 23:52-68.
117. Garlipp M.A., Gonzalez-Fernandez F. Cone photoreceptor and Muller cell pericellular matrices are binding domains for interphotoreceptor retinoid-binding protein (IRBP). Exp. Eye Res. 2013, 113:192-202.
118. Gaynor P.M., et al. Cholesterol accumulation in human cornea: evidence that extracellular cholesteryl ester-rich lipid particles deposit independently of foam cells. J. Lipid Res. 1996, 37:1849-1861.
119. Gehlbach P., et al. Statins for age-related macular degeneration. Cochrane Database Syst. Rev. 2012, 3:CD006927.
120. Genead M.A., et al. Spectral-domain optical coherence tomography and fundus autofluorescence characteristics in patients with fundus albipunctatus and retinitis punctata albescens. Ophthalmic Genet. 2010, 31:66-72.
121. George K.S., Wu S. Lipid raft: a floating island of death or survival. Toxicol. Appl. Pharmacol. 2012, 259:311-319.
122. Giddens D.P., et al. The role of fluid mechanics in the localization and detection of atherosclerosis. J. Biomech. Eng. 1993, 115:588-594.
123. Gordiyenko N., et al. RPE cells internalize low-density lipoprotein (LDL) and oxidized LDL (oxLDL) in large quantities invitro and invivo. Investig. Ophthalmol. Vis. Sci. 2004, 45:2822-2829.
124. Green W.R., Enger C. Age-related macular degeneration histopathologic studies: the 1992 Lorenz E. Zimmerman Lecture. Ophthalmology 1993, 100:1519-1535.
125. Guarneri P., et al. Neurosteroidogenesis in rat retinas. J. Neurochem. 1994, 63:86-96.
126. Gulcan H.G., et al. Lipids of human retina, retinal pigment epithelium, and Bruch's membrane/choroid: comparison of macular and peripheral regions. Investig. Ophthalmol. Vis. Sci. 1993, 34:3187-3193.
127. Guymer R.H., et al. Proof of concept, randomized, placebo-controlled study of the effect of simvastatin on the course of age-related macular degeneration. PloS One 2013, 8:e83759.
128. Guyton J.R., Klemp K.F. The lipid-rich core region of human atherosclerotic fibrous plaques. Prevalence of small lipid droplets and vesicles by electron microscopy. Am. J. Pathol. 1989, 134:705-717.
129. Guyton J.R., Klemp K.R. Development of the lipid-rich core in human atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 1996, 16:4-11.
130. Haimovici R., et al. The lipid composition of drusen, Bruch's membrane, and sclera by hot stage polarizing microscopy. Investig. Ophthalmol. Vis. Sci. 2001, 42:1592-1599.
131. Hayes K.C., et al. Retinal pigment epithelium possesses both LDL and scavenger receptor activity. Investig. Ophthalmol. Vis. Sci. 1989, 30:225-232.
132. Heo G.Y., et al. Conversion of 7-ketocholesterol to oxysterol metabolites by recombinant CYP27A1 and retinal pigment epithelial cells. J. Lipid Res. 2011, 52:1117-1127.
133. Heo G.Y., et al. Features of the retinal environment which affect the activities and product profile of cholesterol-metabolizing cytochromes P450 CYP27A1 and CYP11A1. Arch. Biochem. Biophys. 2012, 518:119-126.
134. Hicks D.A., et al. Lipid rafts and Alzheimer's disease: protein-lipid interactions and perturbation of signaling. Front. Physiol. 2012, 3:189.
135. Hoang Q., et al. Photoreceptor inner segments in monkey and human retina: mitochondrial density, optics, and regional variation. Vis. Neurosci. 2002, 19:395-407.
136. Hogan M.J. Role of the retinal pigment epithelium in macular disease. Trans. Am. Acad. Ophthalmol. Otolaryngol. 1972, 76:64-80.
137. Hollyfield J.G., et al. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat. Med. 2008, 14:194-198.
138. Holz F.G., et al. Analysis of lipid deposits extracted from human macular and peripheral Bruch's membrane. Arch. Ophthalmol. 1994, 112:402-406.
139. Hu J., Bok D. Acell culture medium that supports the differentiation of human retinal pigment epithelium into functionally polarized monolayers. Mol. Vis. 2001, 7:14-19.
140. Hu Y., et al. Anovel approach for subretinal implantation of ultrathin substrates containing stem cell-derived retinal pigment epithelium monolayer. Ophthalmic. Res. 2012, 48:186-191.
141. Huang J.-D., et al. Age-related changes in human macular Bruch's membrane as seen by quick-freeze/deep-etch. Exp. Eye Res. 2007, 85:202-218.
142. Ishida B.Y., et al. Regulated expression of apolipoprotein E by human retinal pigment epithelial cells. J. Lipid Res. 2004, 45:263-271.
143. Jaliffa C.O., et al. Effect of neurosteroids on the retinal gabaergic system and electroretinographic activity in the golden hamster. J. Neurochem. 2005, 94:1666-1675.
144. Janowski B.A., et al. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 1996, 383:728-731.
145. Javitt N.B., Javitt J.C. The retinal oxysterol pathway: a unifying hypothesis for the cause of age-related macular degeneration. Curr. Opin. Ophthalmol. 2009, 20:151-157.
146. Johnson L.V., et al. Cell culture model that mimics drusen formation and triggers complement activation associated with age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:18277-18282.
147. Jonasson F., et al. Prevalence of age-related macular degeneration in old persons: age, gene/environment susceptibility reykjavik study. Ophthalmology 2011, 118:825-830.
148. Kalaany N.Y., Mangelsdorf D.J. LXRS and FXR: the yin and yang of cholesterol and fat metabolism. Annu. Rev. Physiol. 2006, 68:159-191.
149. Kitteringham N.R., et al. Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2009, 877:1229-1239.
150. Klaver C.C., et al. Genetic association of apolipoprotein E with age-related macular degeneration. Am. J. Hum. Genet. 1998, 63:200-206.
151. Klein R., et al. The Wisconsin age-related maculopathy grading system. Ophthalmology 1991, 98:1128-1134.
152. Klein R., et al. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 2007, 114:253-262.
153. Knupp C., et al. Structure of abnormal molecular assemblies (collagen VI) associated with human full thickness macular holes. J. Struct. Biol. 2000, 129:38-47.
154. Kooijman A.C. Light distribution on the retina of a wide-angle theoretical eye. J. Opt. Soc. Am. 1983, 73:1544-1550.
155. Kris-Etherton P.M., Dietschy J. Design criteria for studies examining individual fatty acid effects on cardiovascular disease risk factors: human and animal studies. Am. J. Clin. Nutr. 1997, 65:1590S-1596S.
156. Kruth H.S. The fate of lipoprotein cholesterol entering the arterial wall. Curr. Opin. Lipidol. 1997, 8:246-252.
157. Kruth H.S. Receptor-independent fluid-phase pinocytosis mechanisms for induction of foam cell formation with native low-density lipoprotein particles. Curr. Opin. Lipidol. 2011, 22:386-393.
158. Kuhrt H., et al. Changes in CD44 and ApoE immunoreactivities due to retinal pathology of man and rat. J. Hirnforsch. 1997, 38:223-229.
159. Kurumada S., et al. Stage-specific association of apolipoprotein A-I and E in developing mouse retina. Investig. Ophthalmol. Vis. Sci. 2007, 48:1815-1823.
160. Lee J.W., et al. Expression and localization of sterol 27-hydroxylase (CYP27A1) in monkey retina. Exp. Eye Res. 2006, 83:465-469.
161. Lemaire-Ewing S., et al. Lipid rafts: a signalling platform linking lipoprotein metabolism to atherogenesis. Atherosclerosis 2012, 221:303-310.
162. Lengyel I., et al. Association of drusen deposition with choroidal intercapillary pillars in the aging human eye. Investig. Ophthalmol. Vis. Sci. 2004, 45:2886-2892.
163. Li C.-M., et al. Apolipoprotein localization in isolated drusen and retinal apolipoprotein gene expression. Investigative Ophthalmol. Vis. Sci. 2006, 47:3119-3128.
164. Li C.-M., et al. Lipoprotein-like particles and cholesteryl esters in human Bruch's membrane: initial characterization. Investig. Ophthalmol. Vis. Sci. 2005, 46:2576-2586.
165. Li C.-M., et al. Retina expresses microsomal triglyceride transfer protein: implications for age-related maculopathy. J. Lipid Res. 2005, 46:628-640.
166. Li M., et al. Comprehensive analysis of gene expression in human retina and supporting tissues. Hum. Mol. Gen. 2014, (in press).
167. Li X., et al. Liver X receptor modulators: a review of recently patented compounds (2007-2009). Expert Opin. Ther. Pat. 2010, 20:535-562.
168. Liao W.-L., et al. Quantification of cholesterol-metabolizing P450s CYP27A1 and CYP46A1 in neural tissues reveals a lack of enzyme-product correlations in human retina but not human brain. J. Proteome Res. 2011, 10:241-248.
169. Liao W.L., et al. Steroid and protein ligand binding to cytochrome P450 46A1 as assessed by hydrogen-deuterium exchange and mass spectrometry. Biochemistry 2009, 48:4150-4158.
170. Liao W.L., et al. Optimizing the conditions of a multiple reaction monitoring assay for membrane proteins: quantification of cytochrome P450 11A1 and adrenodoxin reductase in bovine adrenal cortex and retina. Anal. Chem. 2010, 82:5760-5767.
171. Loane E., et al. The respective relationships between lipoprotein profile, macular pigment optical density, and serum concentrations of lutein and zeaxanthin. Investig. Ophthalmol. Vis. Sci. 2010, 51:5897-5905.
172. Lommatzsch A., et al. Are low inflammatory reactions involved in exudative age-related macular degeneration? Morphological and immunhistochemical analysis of AMD associated with basal deposits. Graefes Arch. Clin. Exp. Ophthalmol. 2008, 246:803-810.
173. Lund E.G., et al. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:7238-7243.
174. Lund E.G., et al. Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover. J. Biol. Chem. 2003, 278:22980-22988.
175. Lutjohann D., et al. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:9799-9804.
176. Maeda T., et al. Retinal pigmented epithelial cells obtained from human induced pluripotent stem cells possess functional visual cycle enzymes invitro and invivo. J. Biol. Chem. 2013, 288:34484-34493.
177. Malek A.M., et al. Hemodynamic shear stress and its role in atherosclerosis. JAMA 1999, 282:2035-2042.
178. Malek G., et al. Apolipoprotein B in cholesterol-containing drusen and basal deposits in eyes with age-related maculopathy. Am. J. Pathol. 2003, 162:413-425.
179. Maminishkis A., et al. Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue. Investig. Ophthalmol. Vis. Sci. 2006, 47:3612-3624.
180. Marmorstein L.Y., et al. Formation and progression of sub-retinal pigment epithelium deposits in Efemp1 mutation knock-in mice: a model for the early pathogenic course of macular degeneration. Hum. Mol. Genet. 2007, 16:2423-2432.
181. Marshall J., et al. Aging and Bruch's membrane. The Retinal Pigment Epithelium: Function and Disease 1998, 669-692. Oxford University Press, New York. M.F. Marmor, T.J. Wolfensberger (Eds.).
182. Masland R.H. The fundamental plan of the retina. Nat. Neurosci. 2001, 4:877-886.
183. Mast N., et al. Pharmacologic stimulation of cytochrome P450 46A1 and cerebral cholesterol turnover in mice. J. Biol. Chem. 2014, 289:3529-3538.
184. Mast N., et al. Cholestenoic acid is an important elimination product of cholesterol in the retina: comparison of retinal cholesterol metabolism with that in the brain. Investig. Ophthalmol. Vis. Sci. 2011, 52:594-603.
185. Mata N.L., et al. Isomerization and oxidation of vitamin a in cone-dominant retinas: a novel pathway for visual-pigment regeneration in daylight. Neuron 2002, 36:69-80.
186. Mauch D.H., et al. CNS synaptogenesis promoted by glia-derived cholesterol. Science 2001, 294:1354-1357.
187. McKay G.J., et al. Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies. Hum. Mutat. 2011, 32:1407-1416.
188. Meadway A., et al. Microstructure of sub-retinal drusenoid deposits revealed by adaptive optics imaging. Biomed. Opt. Express 2014, 5:713-727.
189. Meaney S., et al. On the rate of translocation invitro and kinetics invivo of the major oxysterols in human circulation: critical importance of the position of the oxygen function. J. Lipid Res. 2002, 43:2130-2135.
190. Milam A.H., et al. Dominant late-onset retinal degeneration with regional variation of sub-RPE deposits, retinal function, and photoreceptor degeneration. Ophthalmology 2000, 107:2256-2266.
191. Miller J.W. Age-related macular degeneration revisited-piecing the puzzle: the LXIX Edward Jackson memorial lecture. Am. J. Ophthalmol. 2013, 155:1-35 e13.
192. Mimoun G., et al. Macular drusen. J. Fr. Ophtalmol. 1990, 13:511-530.
193. Moore D.J., et al. Age-related variation in the hydraulic conductivity of Bruch's membrane. Investig. Ophthalmol. Vis. Sci. 1995, 36:1290-1297.
194. Moreira E.F., et al. 7-Ketocholesterol is present in lipid deposits in the primate retina: potential implication in the induction of VEGF and CNV formation. Investig. Ophthalmol. Vis. Sci. 2009, 50:523-532.
195. Morgan S.J., et al. Case of cerebrotendinous xanthomatosis. I: unusual ophthalmic features. Br. J. Ophthalmol. 1989, 73:1011-1014.
196. Mossbock G., et al. Role of cholesterol 24S-hydroxylase gene polymorphism (rs754203) in primary open angle glaucoma. Mol. Vis. 2011, 17:616-620.
197. Mrejen S., et al. Assessing the cone photoreceptor mosaic in eyes with pseudodrusen and soft drusen invivo using adaptive optics imaging. Ophthalmology 2014, 121:545-551.
198. Mukkamala S.K., et al. Optical coherence tomographic imaging of sub-retinal pigment epithelium lipid. Arch. Ophthalmol. 2012, 130:1-7.
199. Muniz A., et al. Retinoid uptake, processing and secretion in human iPS-RPE support the visual cycle. Investig. Ophthalmol. Vis. Sci. 2014, 55:198-209.
200. Nakaisumi Y., et al. The ultrastructure of Bruch's membrane. III. The macular area of the human eye. Arch. Ophthalmol. 1964, 72:395-400.
201. Neale B.M., et al. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc. Natl. Acad. Sci. U. S. A. 2010, 107:7395-7400.
202. Noghero A., et al. Liver X receptor activation reduces angiogenesis by impairing lipid raft localization and signaling of vascular endothelial growth factor receptor-2. Arterioscler. Thromb. Vasc. Biol. 2012, 32:2280-2288.
203. Nork T.M., et al. Measurement of regional choroidal blood flow in rabbits and monkeys using fluorescent microspheres. Arch. Ophthalmol. 2006, 124:860-868.
204. Norlin M., Wikvall K. Enzymes in the conversion of cholesterol into bile acids. Curr. Mol. Med. 2007, 7:199-218.
205. O'Byrne S.M., Blaner W.S. Retinol and retinyl esters: biochemistry and physiology. J. Lipid Res. 2013, 54:1731-1743.
206. Oak A.S.W., et al. Subretinal drusenoid deposits: further characterization by lipid histochemistry. Retina 2014, 4:825-826.
207. Oksjoki R., et al. Function and regulation of the complement system in cardiovascular diseases. Front. Biosci. 2007, 12:4696-4708.
208. Omarova S., et al. Abnormal vascularization in mouse retina with dysregulated retinal cholesterol homeostasis. J. Clin. Investig. 2012, 122:3012-3023.
209. Ostlund R.E., et al. Cholesterol absorption efficiency declines at moderate dietary doses in normal human subjects. J. Lipid Res. 1999, 40:1453-1458.
210. Pannu P.S., et al. Oxysterol generation and liver X receptor-dependent reverse cholesterol transport: not all roads lead to Rome. Mol. Cell. Endocrinol. 2013, 368:99-107.
211. Pascolini D., et al. 2002 global update of available data on visual impairment: a compilation of population-based prevalence studies. Ophthalmic. Epidemiol. 2004, 11:67-115.
212. Pauleikhoff D., et al. Aging changes in Bruch's membrane: a histochemical and morphological study. Ophthalmology 1990, 97:171-178.
213. Pflibsen K.P., et al. Retinal illuminance using a wide-angle model of the eye. J. Opt. Soc. Am. Opt. image Sci. 1988, 5:146-150.
214. Pfrieger F.W. Cholesterol homeostasis and function in neurons of the central nervous system. Cell. Mol. Life Sci. 2003, 60:1158-1171.
215. Pfrieger F.W. Outsourcing in the brain: do neurons depend on cholesterol delivery by astrocytes?. Bioessays 2003, 25:72-78.
216. Phillips S.E., et al. Neuronal loss of Drosophila NPC1a causes cholesterol aggregation and age-progressive neurodegeneration. J. Neurosci. 2008, 28:6569-6582.
217. Pike L.J. Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function. J. Lipid Res. 2006, 47:1597-1598.
218. Pikuleva I.A., et al. Activities of recombinant human cytochrome P450c27 (CYP27) which produce intermediates of alternative bile acid biosynthetic pathways. J. Biol. Chem. 1998, 273:18153-18160.
219. Polyak S.L. The Retina 1941, University of Chicago, Chicago.
220. Prosser H.C., et al. The role of cholesterol efflux in mechanisms of endothelial protection by HDL. Curr. Opin. Lipidol. 2012, 23:182-189.
221. Provis J.M., et al. Adaptation of the central retina for high acuity vision: cones, the fovea and the avascular zone. Prog. Retin. Eye Res. 2013, 35:63-81.
222. Qtaishat N.M., et al. Acute radiolabeling of retinoids in eye tissues of normal and rpe65-deficient mice. Investig. Ophthalmol. Vis. Sci. 2003, 44:1435-1446.
223. Querques G., et al. High-definition optical coherence tomographic visualization of photoreceptor layer and retinal flecks in fundus albipunctatus associated with cone dystrophy. Arch. Ophthalmol. 2009, 127:703-706.
224. Querques G., et al. Impact of reticular pseudodrusen on macular function. Retina 2014, 34:321-329.
225. Querques G., et al. Analysis of progression of reticular pseudodrusen by spectral domain optical coherence tomography. Investig. Ophthal. Vis. Sci. 2012, 53:1264-1270.
226. Ramirez D.M., et al. Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain. J. Comp. Neurol. 2008, 507:1676-1693.
227. Reiss A.B., et al. Sterol 27-hydroxylase: expression in human arterial endothelium. J. Lipid Res. 1997, 38:1254-1260.
228. Rodriguez de Turco E.B., et al. Selective retinal pigment epithelial cell lipid metabolism and remodeling conserves photoreceptor docosahexaenoic acid following phagocytosis. J. Neurosci. Res. 1999, 57:479-486.
229. Rodriguez I.R., Larrayoz I.M. Cholesterol oxidation in the retina: Implications of 7-ketocholesterol formation in chronic inflammation and age-related macular degeneration. J. Lipid Res. 2010, 51:2847-2862.
230. Rohrer B., et al. The alternative pathway is required, but not alone sufficient, for retinal pathology in mouse laser-induced choroidal neovascularization. Mol. Immunol. 2011, 48:e1-e8.
231. Rosen H., et al. Markedly reduced bile acid synthesis but maintained levels of cholesterol and vitamin D metabolites in mice with disrupted sterol 27-hydroxylase gene. J. Biol. Chem. 1998, 273:14805-14812.
232. Ruberti J.W., et al. Quick-freeze/deep-etch visualization of age-related lipid accumulation in Bruch's membrane. Investig. Ophthalmol. Vis. Sci. 2003, 44:1753-1759.
233. Rudnicka A.R., et al. Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology 2012, 119:571-580.
234. Rudolf M., et al. Prevalence and morphology of druse types in the macula and periphery of eyes with age-related maculopathy. Investig. Ophthalmol. Vis. Sci. 2008, 49:1200-1209.
235. Rudolf M., et al. ApoA-I mimetic peptide reduces lipid deposition in murine Bruch's membrane after intravitreal injection. Investig. Ophthalmol. Vis. Sci. 2010, 51:2984.
236. Rudolf M., Curcio C.A. Esterified cholesterol is highly localized to Bruch's membrane, as revealed by lipid histochemistry in wholemounts of human choroid. J. Histochem. Cytochem 2009, 57:731-739.
237. Rudolf M., et al. Sub-retinal drusenoid deposits in human retina: organization and composition. Exp. Eye Res. 2008, 87:402-408.
238. Rudolf M. Internal structure consistent with remodeling in very small drusen, revealed by filipin histochemistry for esterified cholesterol. Br. J. Ophthalmol. 2014, 98:698-702.
239. Rudolf M., et al. Increased expression of vascular endothelial growth factor associated with accumulation of lipids in Bruch's membrane of LDL receptor knockout mice. Br. J. Ophthalmol. 2005, 89:1627-1630.
240. Ruiz A., et al. Retinoid content, visual responses, and ocular morphology are compromised in the retinas of mice lacking the retinol-binding protein receptor, STRA6. Investig. Ophthalmol. Vis. Sci. 2012, 53:3027-3039.
241. Russell D.W. 50 years of advances in bile acid synthesis and metabolism. J. Lipid Res. 2008, S120-S125.
242. Rust S., et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat. Genet. 1999, 22:352-355.
243. Rye K.A., Barter P.J. Cardioprotective functions of HDLs. J. Lipid Res. 2014, 55:168-179.
244. Sabine J.R. Cholesterol 1977, Marcel Dekker, Inc, New York and Basel.
245. Saher G., et al. Cholesterol: a novel regulatory role in myelin formation. Neuroscientist 2011, 17:79-93.
246. Salomon R.G. Levuglandins and isolevuglandins: stealthy toxins of oxidative injury. Antioxid. Redox Signal 2005, 7:185-201.
247. SanGiovanni J.P., et al. The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23. Arch. Ophthalmol. 2008, 126:1274-1279.
248. Sarks J., et al. Evolution of reticular pseudodrusen. Br. J. Ophthalmol. 2011, 95:979-985.
249. Sarks J.P., et al. Evolution of geographic atrophy of the retinal pigment epithelium. Eye 1988, 2:552-577.
250. Sarks J.P., et al. Evolution of soft drusen in age-related macular degeneration. Eye 1994, 8:269-283.
251. Sarks S., et al. Relationship of basal laminar deposit and membranous debris to the clinical presentation of early age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 2007, 48:968-977.
252. Sarks S.H. Ageing and degeneration in the macular region: a clinico-pathological study. Br. J. Ophthalmol. 1976, 60:324-341.
253. Sarks S.H., et al. Softening of drusen and subretinal neovascularization. Trans. Ophthalmol. Soc. U. K. 1980, 100:414-422.
254. Schatz P., et al. Lack of autofluorescence in fundus albipunctatus associated with mutations in RDH5. Retina 2010, 30:1704-1713.
255. Schmitz-Valckenberg S., et al. Reticular drusen associated with geographic atrophy in age-related macular degeneration. Investig. Ophthal. Vis. Sci. 2011, 52:5009-5015.
256. Schneeberger S.A., et al. Apolipoprotein E in the subretinal fluid of rhegmatogenous and exudative retinal detachments. Retina 1997, 17:38-43.
257. Schultz J.R., et al. Role of LXRs in control of lipogenesis. Genes. Dev. 2000, 14:2831-2838.
258. Seddon J.M., et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. J. Am. Med. Assoc. 1994, 272:1413-1420.
259. Seddon J.M., et al. Evaluation of the clinical age-related maculopathy staging system. Ophthalmology 2006, 113:260-266.
260. Sene A., et al. Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration. Cell. Metab. 2013, 17:549-561.
261. Shanmugaratnam J., et al. Retinal Muller glia secrete apolipoproteins E and J which are efficiently assembled into lipoprotein particles. Mol. Brain Res. 1997, 50:113-120.
262. Shen J.K., et al. Oxidative damage in age-related macular degeneration. Histol. Histopathol. 2007, 22:1301-1308.
263. Sheraidah G., et al. Correlation between lipids extracted from Bruch's membrane and age. Ophthalmology 1993, 100:47-51.
264. Small D.M. George Lyman Duff memorial lecture. Progression and regression of atherosclerotic lesions. Insights from lipid physical biochemistry. Arteriosclerosis 1988, 8:103-129.
265. Smith E.B. The relationship between plasma and tissue lipids in human atherosclerosis. Adv. Lipid Res. 1974, 12:1-49.
266. Smith R.T., et al. Autofluorescence characteristics of early, atrophic, and high-risk fellow eyes in age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 2006, 47:5495-5504.
267. Smith W., et al. Risk factors for age-related macular degeneration. Pooled findings from three continents. Ophthalmology 2001, 108:697-704.
268. Soh J., et al. MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion. Nat. Med. 2013, 19:892-900.
269. Solomon A., et al. Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. Dement. Geriatr. Cogn. Disord. 2009, 28:75-80.
270. Sonoda S., et al. Aprotocol for the culture and differentiation of highly polarized human retinal pigment epithelial cells. Nat. Protoc. 2009, 4:662-673.
271. Souied E.H., et al. The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am. J. Ophthalmol. 1998, 125:353-359.
272. Spady D.K., et al. Rates of low density lipoprotein uptake and cholesterol synthesis are regulated independently in the liver. J. Lipid Res. 1985, 26:465-472.
273. Spaide R., Curcio C.A. Anatomic correlates to the bands seen in the outer retina by optical coherence tomography: literature review and model. Retina 2011, 31:1609-1619.
274. Spaide R., et al. Characterization of peroxidized lipids in Bruch's membrane. Retina 1999, 19:141-147.
275. Spaide R.F. Outer retinal atrophy after regression of subretinal drusenoid deposits as a newly recognized form of late age-related macular degeneration. Retina 2013, 33:1800-1808.
276. Spaide R.F., et al. Continuing medical education review: choroidal neovascularization in age-related macular degeneration-what is the cause?. Retina 2003, 23:595-614.
277. Spaide R.F., Curcio C.A. Drusen characterization with multimodal imaging. Retina 2010, 30:1441-1454.
278. Sparks C.E., et al. Hepatic and intestinal contribution of two forms of apolipoprotein B to plasma lipoprotein fractions in the rat. Can. J. Biochem 1981, 59:693-699.
279. Starita C., et al. Decreasing hydraulic conductivity of Bruch's membrane: relevance to photoreceptor survival and lipofuscinoses. Am. J. Med. Genet. 1995, 57:235-237.
280. Starita C., et al. Localization of the site of major resistance to fluid transport in Bruch's membrane. Investigative Ophthalmol. Vis. Sci. 1997, 38:762-767.
281. Stary H.C. Composition and classification of human atherosclerotic lesions. Virchows Arch. A Pathol. Anat. 1992, 421:277-290.
282. Stary H.C., et al. Adefinition of the intima of human arteries and of its atherosclerosis-prone regions. Circulation 1992, 85:391-405.
283. Steinberg D. Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: part I. J. Lipid Res. 2004, 45:1583-1593.
284. Steinberg D. Thematic review series: the pathogenesis of atherosclerosis: an interpretive history of the cholesterol controversy, part III: mechanistically defining the role of hyperlipidemia. J. Lipid Res. 2005, 46:2037-2051.
285. Steinberg D. Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: part II: the early evidence linking hypercholesterolemia to coronary disease in humans. J. Lipid Res. 2005, 46:179-190.
286. Steinberg D. The pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part IV: the 1984 coronary primary prevention trial ends it-almost. J. Lipid Res. 2006, 47:1-14.
287. Steinberg D. Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part V: the discovery of the statins and the end of the controversy. J. Lipid Res. 2006, 47:1339-1351.
288. Streeten B.W. The sudanophilic granules of the human retinal pigment epithelium. Arch. Ophthalmol. 1961, 66:391-398.
289. Sudhop T., et al. Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Circulation 2002, 106:1943-1948.
290. Suzuki M., et al. Oxidized phospholipids in the macula increase with age and in eyes with age-related macular degeneration. Mol. Vis. 2007, 13:772-778.
291. Tabas I., et al. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 2007, 116:1832-1844.
292. Thomas G.S., et al. Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial. J. Am. College Cardiol. 2013, 62:2178-2184.
293. Thomas T., Ginsberg H. Development of apolipoprotein B antisense molecules as a therapy for hyperlipidemia. Curr. Atheroscler. Rep. 2010, 12:58-65.
294. Treharne A.J., et al. Developing methacrylate-based copolymers as an artificial Bruch's membrane substitute. J. Biomed. Mat. Res. Part A 2012, 100:2358-2364.
295. Tsao S.W., Fong D.S. Do statins have a role in the prevention of age-related macular degeneration?. Drugs Aging 2013, 30:205-213.
296. Tserentsoodol N., et al. Intraretinal lipid transport is dependent on high density lipoprotein-like particles and class B scavenger receptors. Mol. Vis. 2006, 12:1319-1333.
297. Tserentsoodol N., et al. Uptake of cholesterol by the retina occurs primarily via a low density lipoprotein receptor-mediated process. Mol. Vis. 2006, 12:1306-1318.
298. Turley S.D., Dietschy J.M. Sterol absorption by the small intestine. Curr. Opin. Lipidol. 2003, 14:233-240.
299. Turley S.D., et al. Gender-related differences in bile acid and sterol metabolism in outbred CD-1 mice fed low- and high-cholesterol diets. Hepatology 1998, 28:1088-1094.
300. Turley S.D., et al. Role of liver in the synthesis of cholesterol and the clearance of low density lipoproteins in the cynomolgus monkey. J. Lipid Res. 1995, 36:67-79.
301. Ueda-Arakawa N., et al. Prevalence and genomic association of reticular pseudodrusen in age-related macular degeneration. Am. J. Ophthalmol. 2012, 155:260-269. e262.
302. Upston J.M., et al. Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis. Am. J. Pathol. 2002, 160:701-710.
303. Vaisar T., et al. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J. Clin. Investig. 2007, 117:746-756.
304. van Leeuwen R., et al. Cholesterol and age-related macular degeneration: is there a link?. Am. J. Ophthalmol. 2004, 137:750-752.
305. Van Lenten B.J., et al. Apolipoprotein A-I mimetic peptides. Curr. Atheroscler. Rep. 2009, 11:52-57.
306. VanderLaan P.A., et al. Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler. Thromb. Vasc. Biol. 2004, 24:12-22.
307. Verhoeff F.H., Sisson R.J. Basophilic staining of Bruch's membrane. Arch. Ophthalmol. 1926, 55:125-127.
308. Vogel S., et al. Retinol-binding protein-deficient mice: biochemical basis for impaired vision. Biochemistry 2002, 41:15360-15368.
309. Walczak R., et al. Transcription of the vascular endothelial growth factor gene in macrophages is regulated by liver X receptors. J. Biol. Chem. 2004, 279:9905-9911.
310. Wang A.L., et al. Autophagy and exosomes in the aged retinal pigment epithelium: possible relevance to drusen formation and age-related macular degeneration. PloS One 2009, 4:e4160.
311. Wang L., et al. Abundant lipid and protein components of drusen. PloS One 2010, 5:e10329.
312. Wang L., et al. Lipoprotein particles of intra-ocular origin in human Bruch membrane: an unusual lipid profile. Investig. Ophthalmol. Vis. Sci. 2009, 50:870-877.
313. Wang M., et al. Sample prefractionation for mass spectrometry quantification of low-abundance membrane proteins. Anal. Chem. 2012, 84:5186-5191.
314. Wavre-Shapton S.T., et al. Conditional ablation of the choroideremia gene causes age-related changes in mouse retinal pigment epithelium. PloS One 2013, 8:e57769.
315. Weber C., Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat. Med. 2011, 17:1410-1422.
316. Wedl C. Grundzüge der pathologischen Histologie (Translated by G. Busk) 1854, Carl Gerold & Sohn, Vienna.
317. Weismann D., et al. Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 2011, 478:76-81.
318. Wierzbicki A.S., et al. Future challenges for microsomal transport protein inhibitors. Curr. Vasc. Pharmacol. 2009, 7:277-286.
319. Williams K.J., Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 1995, 15:551-561.
320. Williams K.J., Tabas I. The response-to-retention hypothesis of atherogenesis reinforced. Curr. Opin. Lipidol. 1998, 9:471-474.
321. Wolter J.R., Falls H.F. Bilateral confluent drusen. Arch. Ophthalmol. 1962, 68:219-226.
322. Wong P., et al. Clusterin protein diversity in the primate eye. Mol. Vis. 2000, 6:184-191.
323. Wu M., et al. Intraretinal leakage and oxidation of LDL in diabetic retinopathy. Investig. Ophthalmol. Vis. Sci. 2008, 49:2679-2685.
324. Wu T., et al. Apolipoprotein B100 secretion by cultured ARPE-19 cells is modulated by alteration of cholesterol levels. J. Neurochem. 2010, 114:1734-1744.
325. Xu L., et al. Novel oxysterols observed in tissues and fluids of AY9944-treated rats: a model for Smith-Lemli-Opitz syndrome. J. Lipid Res. 2011, 52:1810-1820.
326. Xu L., et al. 7-Dehydrocholesterol-derived oxysterols and retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome. Biochim. Biophys. Acta 2012, 1821:877-883.
327. Yehoshua Z., et al. Natural history of drusen morphology in age-related macular degeneration using spectral domain optical coherence tomography. Ophthalmology 2011, 118:2434-2441.
328. Yu Y., et al. Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration. Investig. Ophthalmol. Vis. Sci. 2011, 52:4663-4670.
329. Yu Y., et al. Prospective assessmentof genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models. Investig. Ophthalmol. Vis. Sci. 2012, 53:1548-1556.
330. Zak Z., et al. Expression of simian CETP in normolipidemic Fisher rats has a profound effect on large sized apoE-containing HDL. J. Lipid Res. 2002, 43:2164-2171.
331. Zambon D., et al. Higher incidence of mild cognitive impairment in familial hypercholesterolemia. Am. J. Med. 2010, 123:267-274.
332. Zelcer N., Tontonoz P. Liver X receptors as integrators of metabolic and inflammatory signaling. J. Clin. Investig. 2006, 116:607-614.
333. Zhang Z., et al. Apolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic rats. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H866-H873.
334. Zheng W., et al. Spatial distribution of the pathways of cholesterol homeostasis in human retina. PloS One 2012, 7:e37926.
335. Zweifel S.A., et al. Reticular pseudodrusen are subretinal drusenoid deposits. Ophthalmology 2010, 117:303-312.e.301.